Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoru Tsuchiya

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 26, 2024
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis BNobuharu Tamaki, Mayu Higuchi, Taisei Keitoku, et al.
Plos One|August 16, 2016
Correction: Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Journal of Medical Virology|January 30, 2020
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis BNobuharu Tamaki, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Plos One|October 14, 2025
Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and olderKenta Takaura, Kaoru Tsuchiya, Mina Taguchi, et al.
Cancer Reports (Hoboken, N.J.)|March 18, 2022
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapyShuhei Sekiguchi, Kaoru Tsuchiya, Yutaka Yasui, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Atsushi Kuno, et al.
Journal of Medical Virology|December 31, 2016
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patientsMiyako Murakawa, Yasuhiro Asahina, Fukiko Kawai-Kitahata, et al.
BMC Cancer|March 12, 2025
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinomaYoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, et al.
Plos One|April 30, 2016
Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study GroupKeiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 26, 2024
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis BNobuharu Tamaki, Mayu Higuchi, Taisei Keitoku, et al.
Plos One|August 16, 2016
Correction: Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Journal of Medical Virology|January 30, 2020
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis BNobuharu Tamaki, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Plos One|October 14, 2025
Clinical outcome of radiofrequency ablation in patients with hepatocellular carcinoma aged 80 years and olderKenta Takaura, Kaoru Tsuchiya, Mina Taguchi, et al.
Cancer Reports (Hoboken, N.J.)|March 18, 2022
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapyShuhei Sekiguchi, Kaoru Tsuchiya, Yutaka Yasui, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 7, 2015
Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patientsNobuharu Tamaki, Masayuki Kurosaki, Atsushi Kuno, et al.
Journal of Medical Virology|December 31, 2016
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patientsMiyako Murakawa, Yasuhiro Asahina, Fukiko Kawai-Kitahata, et al.
BMC Cancer|March 12, 2025
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinomaYoshihisa Kodama, Kazuomi Ueshima, Michihisa Moriguchi, et al.
Plos One|April 30, 2016
Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Pemafibrate improves liver biochemistry and GLOBE scores in patients with primary biliary cholangitis: Nationwide, multicenter study by the Japanese Red Cross Liver Study GroupKeiji Tsuji, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 15